Published in Women's Health Weekly, October 3rd, 2002
Researchers studied depot medroxyprogesterone acetate (DMPA), commonly known by the brand name Depo-Provera. The drug affects the arteries' ability to "respond to different stimuli and particularly affects the ability of the artery to dilate," said senior author, Dudley J. Pennell, MD, a professor of cardiology at the Imperial College School of Medicine in London. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.